BIT:GVS • IT0005411209
The current stock price of GVS.MI is 3.87 EUR. Today GVS.MI is down by -1.9%. In the past month the price decreased by -4.21%. In the past year, price decreased by -17.66%.
ChartMill assigns a technical rating of 1 / 10 to GVS.MI. When comparing the yearly performance of all stocks, GVS.MI is a bad performer in the overall market: 79.76% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to GVS.MI. There are concerns on the financial health of GVS.MI while its profitability can be described as average.
On November 12, 2025 GVS.MI reported an EPS of 0.06 and a revenue of 101.10M. The company missed EPS expectations (-25.74% surprise) and missed revenue expectations (-11.86% surprise).
9 analysts have analysed GVS.MI and the average price target is 5.94 EUR. This implies a price increase of 53.4% is expected in the next year compared to the current price of 3.87.
For the next year, analysts expect an EPS growth of -5.98% and a revenue growth -1.44% for GVS.MI
Over the last trailing twelve months GVS.MI reported a non-GAAP Earnings per Share(EPS) of 0.09. The EPS decreased by -40.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.58% | ||
| ROA | 1.65% | ||
| ROE | 3.41% | ||
| Debt/Equity | 0.58 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 2M6 | MEDTRONIC PLC | 15.74 | 107.471B | ||
| SHL | SIEMENS HEALTHINEERS AG | 14.98 | 46.665B | ||
| 1PHIA | KONINKLIJKE PHILIPS NV | 17.51 | 25.662B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 16.88 | 25.325B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 16.94 | 25.287B | ||
| BIM | BIOMERIEUX | 19.74 | 11.954B | ||
| DIA | DIASORIN SPA | 17.06 | 3.97B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 18.5 | 3.711B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 10.75 | 2.308B | ||
| DRW3 | DRAEGERWERK AG - PREF | 11.88 | 1.672B | ||
| DRW8 | DRAEGERWERK AG | 9.51 | 1.384B | ||
| ELN | EL.EN. SPA | 21.43 | 1.12B | ||
| EUZ | ECKERT & ZIEGLER SE | 17.58 | 959.787M |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
GVS SpA engages in the manufacture of filter solutions for the healthcare and life sciences, energy and mobility, and health and safety industry application sectors. The company is headquartered in Zola Predosa, Bologna and currently employs 4,234 full-time employees. The company went IPO on 2020-06-19. Its offering includes seven product lines: Healthcare, Laboratory, Mobility, Air Safety, Appliance, Personal Safety and Membranes. Each product line provides a suite of customizable solutions specifically related to each market. Additionally, the Company offers tailormade product and process development services, which cover all the project stages, including product and process design, validation, up to the mass production for large quantities. The company is active globally.
GVS SPA
Via Roma, 50
Zola Predosa BOLOGNA IT
Employees: 4234
Phone: 390516176311
GVS SpA engages in the manufacture of filter solutions for the healthcare and life sciences, energy and mobility, and health and safety industry application sectors. The company is headquartered in Zola Predosa, Bologna and currently employs 4,234 full-time employees. The company went IPO on 2020-06-19. Its offering includes seven product lines: Healthcare, Laboratory, Mobility, Air Safety, Appliance, Personal Safety and Membranes. Each product line provides a suite of customizable solutions specifically related to each market. Additionally, the Company offers tailormade product and process development services, which cover all the project stages, including product and process design, validation, up to the mass production for large quantities. The company is active globally.
The current stock price of GVS.MI is 3.87 EUR. The price decreased by -1.9% in the last trading session.
GVS.MI does not pay a dividend.
GVS.MI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
GVS SPA (GVS.MI) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
GVS SPA (GVS.MI) will report earnings on 2026-03-23, after the market close.